137 related articles for article (PubMed ID: 34596829)
1. Triptolide Alleviates Podocyte Epithelial-Mesenchymal Transition via Kindlin-2 and EMT-Related TGF-β/Smad Signaling Pathway in Diabetic Kidney Disease.
Ren L; Wan R; Chen Z; Huo L; Zhu M; Yang Y; Chen Q; Zhang X; Wang X
Appl Biochem Biotechnol; 2022 Feb; 194(2):1000-1012. PubMed ID: 34596829
[TBL] [Abstract][Full Text] [Related]
2. [Low dose of triptolide ameliorates podocyte epithelial-mesenchymal transition induced by high dose of D-glucose via inhibiting Wnt3α/β-catenin signaling pathway activation].
Shi G; Wu W; Wan YG; Hex HW; Tu Y; Han WB; Liu BH; Liu YL; Wan ZY
Zhongguo Zhong Yao Za Zhi; 2018 Jan; 43(1):139-146. PubMed ID: 29552824
[TBL] [Abstract][Full Text] [Related]
3. Tangzhiqing Granules Alleviate Podocyte Epithelial-Mesenchymal Transition in Kidney of Diabetic Rats.
Xu H; Wang X; Liu M; He X
Evid Based Complement Alternat Med; 2017; 2017():1479136. PubMed ID: 28163747
[TBL] [Abstract][Full Text] [Related]
4. Effect of Tang-Shen-Ning decoction on podocyte epithelial-esenchymal transformation via inhibiting Wnt/β-catenin pathway in diabetic mice.
Cui FQ; Gao YB; Wang YF; Meng Y; Cai Z; Shen C; Jiang XC; Zhao WJ
Ann Palliat Med; 2021 Dec; 10(12):12921-12936. PubMed ID: 32921066
[TBL] [Abstract][Full Text] [Related]
5. Hesperetin inhibit EMT in TGF-β treated podocyte by regulation of mTOR pathway.
Choi D; Kim CL; Kim JE; Mo JS; Jeong HS
Biochem Biophys Res Commun; 2020 Jul; 528(1):154-159. PubMed ID: 32451085
[TBL] [Abstract][Full Text] [Related]
6. [Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose].
Wu W; Liu BH; Wan YG; Sun W; Liu YL; Wang WW; Fang QJ; Tu Y; Yee HY; Yuan CC; Wan ZY
Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5457-5464. PubMed ID: 32237395
[TBL] [Abstract][Full Text] [Related]
7. Laminaria japonica polysaccharide attenuates podocyte epithelial-mesenchymal transformation via TGF-β1-mediated Smad3 and p38MAPK pathways.
Li XY; Chen HR; Kuang DD; Pan LH; Li QM; Luo JP; Zha XQ
Int J Biol Macromol; 2023 Jun; 241():124637. PubMed ID: 37121417
[TBL] [Abstract][Full Text] [Related]
8. Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway.
Wang M; Chen DQ; Wang MC; Chen H; Chen L; Liu D; Zhao H; Zhao YY
Phytomedicine; 2017 Dec; 36():243-253. PubMed ID: 29157821
[TBL] [Abstract][Full Text] [Related]
9. Jixuepaidu Tang-1 inhibits epithelial-mesenchymal transition and alleviates renal damage in DN mice through suppressing long non-coding RNA LOC498759.
Jin J; Zhang Z; Chen J; Liu Y; Chen Q; Wang Q
Cell Cycle; 2019 Nov; 18(22):3125-3136. PubMed ID: 31564202
[TBL] [Abstract][Full Text] [Related]
10. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
[TBL] [Abstract][Full Text] [Related]
11. Tangeretin Ameliorates Glucose-Induced Podocyte Injury through Blocking Epithelial to Mesenchymal Transition Caused by Oxidative Stress and Hypoxia.
Kang MK; Kim SI; Oh SY; Na W; Kang YH
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202982
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux.
Jin J; Gong J; Zhao L; Zhang H; He Q; Jiang X
J Diabetes; 2019 Oct; 11(10):826-836. PubMed ID: 30864227
[TBL] [Abstract][Full Text] [Related]
13. The influence of angiopoietin-like protein 3 on macrophages polarization and its effect on the podocyte EMT in diabetic nephropathy.
Ma Y; Chen Y; Xu H; Du N
Front Immunol; 2023; 14():1228399. PubMed ID: 37638046
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms involved in podocyte EMT and concomitant diabetic kidney diseases: an update.
Ying Q; Wu G
Ren Fail; 2017 Nov; 39(1):474-483. PubMed ID: 28413908
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of FOXO1 ameliorates the podocyte epithelial-mesenchymal transition induced by high glucose in vitro and in vivo.
Du M; Wang Q; Li W; Ma X; Wu L; Guo F; Zhao S; Huang F; Wang H; Qin G
Biochem Biophys Res Commun; 2016 Mar; 471(4):416-22. PubMed ID: 26902117
[TBL] [Abstract][Full Text] [Related]
16. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.
Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH
Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292
[TBL] [Abstract][Full Text] [Related]
17. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
18. Triptolide protects podocytes from TGF-β-induced injury by preventing miR-30 downregulation.
Yang Q; Sun M; Chen Y; Lu Y; Ye Y; Song H; Xu X; Shi S; Wang J
Am J Transl Res; 2017; 9(11):5150-5159. PubMed ID: 29218112
[TBL] [Abstract][Full Text] [Related]
19. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
[TBL] [Abstract][Full Text] [Related]
20. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
